Cargando…
Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report
The neurologic manifestations concerning coronavirus disease 2019 (COVID-19) are highly penetrated. Anosmia and ageusia are one of the common acute neurologic symptoms, which develop in the early stage of COVID-19. However, it is not reported that how immunosuppressive agents affect these symptoms....
Autores principales: | Lee, Jong-Mok, Lee, Sang Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261700/ https://www.ncbi.nlm.nih.gov/pubmed/32476306 http://dx.doi.org/10.3346/jkms.2020.35.e201 |
Ejemplares similares
-
Infertility improved by etanercept in ankylosing spondylitis
por: Rezvani, Aylin, et al.
Publicado: (2008) -
Treatment of ankylosing spondylitis: focus on etanercept
por: Frech, Tracy
Publicado: (2007) -
Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept
por: Raffeiner, Bernd, et al.
Publicado: (2014) -
Safety and Clinical Responses in Ankylosing Spondylitis after Three Months of Etanercept Therapy
por: Choi, Chan-Bum, et al.
Publicado: (2008) -
Treatment and Prognosis of COVID-19 Associated Olfactory and Gustatory Dysfunctions
por: Seo, Min Young, et al.
Publicado: (2021)